Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Terumo Corp    4543   JP3546800008

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Terumo : Expands Production in Asia New Factory Established and Existing Facilities Expanded in Vietnam and the Philippines

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/10/2012 | 08:13am CEST
May 10, 2012

Terumo Corporation (TOKYO:4543) announced today that it will expand its production facilities in Asia to meet anticipated sales increases in the medium to long term, based on its corporate growth strategy. Terumo Corporation will establish a new factory in Vietnam, its second in the country, as well as expand the production scale of existing factories in Vietnam and the Philippines. The total amount invested will be 15 billion yen.

The new factory in Vietnam will produce blood management products such as blood bags to meet growing global demand, especially in emerging countries.
In cooperation with Ashitaka factory (Shizuoka prefecture) and the new Yamaguchi factory in Japan (operation to be started in 2015), the existing factory in Vietnam will expand the production scale of interventional systems products, sales of which have been growing at a double-digit pace. The company will also establish a new production building at the existing factory in the Philippines to cope with needed production increases of syringes and needles.
To improve its global competitiveness, Terumo Corporation is seeking to enhance the production capacity across all of its three business areas: Cardiac & Vascular, General Hospital, and Blood Management.

Terumo Corporation's global production system

Terumo Corporation is accelerating its growth globally, and plans to increase the percent of production done outside Japan in line with the growth in the share of net sales outside Japan, which already account for over half of the total. Accordingly, the company has positioned factories in Asia as its global production center and is already producing a broad range of products in China, the Philippines, and Vietnam.
On another front, certain highly advanced and precise production technologies are difficult to transfer outside of Japan. The company has designated factories in Japan as mother production factories that develop and refine core manufacturing technologies to underpin product improvement.
Terumo Corporation will continue to enhance its global production system in factories in Asia and Japan to meet growing global demand while increasing cost competitiveness.

Factories Overview 1. Vietnam: a new factory to be established

In April 2012, Terumo BCT was established through the integration of CaridianBCT and Terumo Transfusion, following Terumo Corporation's acquisition of CaridianBCT in April 2011. The company will establish a new factory in Vietnam to produce blood management products to meet growing global demand, especially in emerging countries. The factory will be its sixth production facilities of blood management products, following ones in Japan, U.S., UK

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on TERUMO CORP
05/23 TERUMO : Announces European Medicines Agency Validates Marketing Authorization A..
05/15 TERUMO : Blood transfusion system in Ghana gets new phase
05/10 TERUMO : Appoints the Candidates for Directors
05/10 TERUMO : Notice Concerning Non-Renewal of a Policy for Large-scale Acquisitions ..
05/10 TERUMO : Notice Regarding Dividend for the Fiscal Year Ended March 31, 2017
05/08 TERUMO : BCT Announces 2016 Advancing Apheresis Award Winner Opens Applications ..
04/13 TERUMO : Cardiovascular Group Announces New President and CEO, Robert DeRyke
04/07 TERUMO : BCT's Spectra Optia® Apheresis System Is the First and Only Device on t..
04/06 GLOBAL ARTIFICIAL HEART LUNG MACHINE : Jarvik Heart, Terumo Corporation, C.R. Ba..
03/29 TERUMO CORP : ex-dividend day for final dividend
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
05/23DJFirms Persuade SEC on Profit Metric -- WSJ
05/22DJCompanies Are Winning the Battle Over Adjusted Earnings
05/16 Earnings drag on European shares, though Vodafone lifts telcos
05/09 French outbound M&A driven to decade high by big deals
05/06DJProfits Jump, Spending Lags -- WSJ
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
2016 HAEMONETICS : Investor Patience Is Wearing Thin
2016 Terumo Corp. ADR 2017 Q2 - Results - Earnings Call Slides
2016 Abbott's Vascular Products Sale Likely Done To Address Regulatory Concerns
2016 Abbott's Vascular Tech Is Big In Japan
2016 Abbott and St. Jude to jettison vascular closure products to Terumo for $1.1B
Advertisement
Financials ( JPY)
Sales 2018 567 360 M
EBIT 2018 -
Net income 2018 55 416 M
Debt 2018 180 378 M
Yield 2018 1,00%
P/E ratio 2018 28,58
P/E ratio 2019 25,58
EV / Sales 2018 3,30x
EV / Sales 2019 3,06x
Capitalization 1 691 833 M
More Financials
Chart TERUMO CORP
Duration : Period :
Terumo Corp Technical Analysis Chart | 4543 | JP3546800008 | 4-Traders
Full-screen chart
Technical analysis trends TERUMO CORP
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 4 832  JPY
Spread / Average Target 8,5%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Shinjiro Sato President, CEO & Representative Director
Takayoshi Mimura Chairman
Ryo Nishihata Chief Accounting & Financial Officer, IR Contact
Hiroaki Kasukawa CTO, Executive Officer, GM-Research & Development
Katsuya Takeuchi Executive Officer & Chief Information Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
TERUMO CORP3.01%15 252
MEDTRONIC PLC19.46%116 478
BAXTER INTERNATIONAL I..32.25%31 881
ZIMMER BIOMET HOLDINGS..15.53%24 042
C R BARD INC37.41%22 355
HOYA CORPORATION10.75%19 151
More Results